Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Matrix | 23 | 2025 | 132 | 6.170 |
Why?
|
| Hydrogels | 14 | 2023 | 110 | 3.720 |
Why?
|
| Biocompatible Materials | 13 | 2025 | 141 | 3.660 |
Why?
|
| Polyethylene Glycols | 12 | 2021 | 165 | 2.300 |
Why?
|
| Breast Neoplasms | 7 | 2023 | 1118 | 1.930 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 140 | 1.690 |
Why?
|
| Astrocytes | 2 | 2024 | 116 | 1.490 |
Why?
|
| Neoplasms | 6 | 2023 | 1240 | 1.490 |
Why?
|
| Brain | 5 | 2024 | 1488 | 1.310 |
Why?
|
| Materials Testing | 3 | 2024 | 82 | 1.260 |
Why?
|
| Bone Marrow | 2 | 2021 | 174 | 1.160 |
Why?
|
| Elastic Modulus | 5 | 2020 | 36 | 1.130 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2018 | 179 | 1.070 |
Why?
|
| Phosphorylcholine | 2 | 2018 | 41 | 0.990 |
Why?
|
| Cell Adhesion | 8 | 2018 | 207 | 0.980 |
Why?
|
| Cell Movement | 8 | 2018 | 429 | 0.970 |
Why?
|
| Mechanical Phenomena | 1 | 2024 | 19 | 0.910 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2024 | 84 | 0.900 |
Why?
|
| Needles | 1 | 2024 | 65 | 0.880 |
Why?
|
| Tenascin | 1 | 2023 | 4 | 0.860 |
Why?
|
| Endometrium | 1 | 2023 | 28 | 0.850 |
Why?
|
| Menstrual Cycle | 1 | 2023 | 81 | 0.830 |
Why?
|
| Hippocampus | 1 | 2024 | 246 | 0.810 |
Why?
|
| Sulfhydryl Compounds | 2 | 2023 | 48 | 0.780 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 300 | 0.780 |
Why?
|
| Biomechanical Phenomena | 6 | 2024 | 242 | 0.740 |
Why?
|
| Polymers | 3 | 2024 | 316 | 0.740 |
Why?
|
| Fibronectins | 2 | 2020 | 43 | 0.730 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 47 | 0.730 |
Why?
|
| Neoplasm Metastasis | 4 | 2021 | 188 | 0.720 |
Why?
|
| Cell Line, Tumor | 10 | 2019 | 1370 | 0.700 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2019 | 26 | 0.660 |
Why?
|
| Animals | 22 | 2025 | 19651 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 3231 | 0.640 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 631 | 0.640 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2009 | 57 | 0.620 |
Why?
|
| Foreign-Body Reaction | 1 | 2018 | 15 | 0.600 |
Why?
|
| Niacinamide | 2 | 2017 | 32 | 0.590 |
Why?
|
| Maleimides | 1 | 2018 | 7 | 0.590 |
Why?
|
| Phenylurea Compounds | 2 | 2017 | 30 | 0.590 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 277 | 0.590 |
Why?
|
| Lung | 2 | 2023 | 919 | 0.570 |
Why?
|
| Humans | 33 | 2025 | 59387 | 0.560 |
Why?
|
| Stress, Mechanical | 8 | 2024 | 110 | 0.540 |
Why?
|
| Cytoskeleton | 3 | 2019 | 137 | 0.480 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 203 | 0.470 |
Why?
|
| rhoA GTP-Binding Protein | 3 | 2009 | 27 | 0.440 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 172 | 0.430 |
Why?
|
| Carcinoma | 1 | 2014 | 116 | 0.420 |
Why?
|
| Cells, Cultured | 7 | 2019 | 2093 | 0.400 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2008 | 31 | 0.370 |
Why?
|
| Tissue Engineering | 3 | 2025 | 134 | 0.360 |
Why?
|
| Integrins | 3 | 2023 | 106 | 0.350 |
Why?
|
| Cell Culture Techniques | 3 | 2008 | 178 | 0.340 |
Why?
|
| Female | 12 | 2024 | 30728 | 0.340 |
Why?
|
| Mice | 10 | 2024 | 10295 | 0.330 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 276 | 0.320 |
Why?
|
| Fibroblasts | 2 | 2023 | 377 | 0.320 |
Why?
|
| Rheology | 3 | 2020 | 71 | 0.310 |
Why?
|
| Focal Adhesions | 4 | 2013 | 23 | 0.310 |
Why?
|
| Cell Communication | 2 | 2019 | 124 | 0.290 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2025 | 33 | 0.290 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 65 | 0.290 |
Why?
|
| Systems Biology | 2 | 2017 | 29 | 0.260 |
Why?
|
| Fibrinogen | 3 | 2011 | 31 | 0.240 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2025 | 4 | 0.240 |
Why?
|
| Trypsin | 1 | 2025 | 39 | 0.240 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2025 | 81 | 0.230 |
Why?
|
| Nanotubes | 1 | 2024 | 23 | 0.230 |
Why?
|
| Pyramidal Cells | 1 | 2024 | 26 | 0.230 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2024 | 36 | 0.230 |
Why?
|
| Pressure | 1 | 2024 | 76 | 0.230 |
Why?
|
| Psoriasis | 1 | 2024 | 50 | 0.230 |
Why?
|
| Organoids | 2 | 2025 | 40 | 0.230 |
Why?
|
| Brain Concussion | 1 | 2024 | 28 | 0.220 |
Why?
|
| Neuroglia | 1 | 2024 | 79 | 0.220 |
Why?
|
| Models, Biological | 4 | 2018 | 1143 | 0.210 |
Why?
|
| Mass Behavior | 1 | 2023 | 4 | 0.210 |
Why?
|
| Epithelium | 1 | 2023 | 96 | 0.210 |
Why?
|
| Cell Survival | 3 | 2018 | 559 | 0.210 |
Why?
|
| Faculty | 1 | 2023 | 51 | 0.210 |
Why?
|
| Reproduction | 1 | 2023 | 89 | 0.210 |
Why?
|
| Personnel Selection | 1 | 2023 | 50 | 0.210 |
Why?
|
| Disulfides | 1 | 2023 | 62 | 0.200 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 250 | 0.200 |
Why?
|
| Physical Phenomena | 1 | 2022 | 9 | 0.200 |
Why?
|
| Cell Division | 1 | 2024 | 443 | 0.200 |
Why?
|
| Explosions | 1 | 2022 | 6 | 0.200 |
Why?
|
| Brain Injuries | 1 | 2024 | 135 | 0.200 |
Why?
|
| Drug Resistance | 1 | 2022 | 95 | 0.190 |
Why?
|
| Cell Lineage | 1 | 2023 | 259 | 0.190 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 24 | 0.190 |
Why?
|
| Inflammasomes | 1 | 2024 | 324 | 0.180 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 59 | 0.170 |
Why?
|
| Biophysics | 2 | 2013 | 41 | 0.170 |
Why?
|
| Integrin alpha5beta1 | 1 | 2020 | 4 | 0.170 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2020 | 14 | 0.170 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2020 | 28 | 0.170 |
Why?
|
| Cell Proliferation | 4 | 2013 | 942 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2020 | 57 | 0.160 |
Why?
|
| Peptides | 1 | 2023 | 549 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 157 | 0.160 |
Why?
|
| White Matter | 1 | 2020 | 114 | 0.160 |
Why?
|
| Lung Compliance | 1 | 2018 | 5 | 0.160 |
Why?
|
| Freezing | 1 | 2018 | 18 | 0.150 |
Why?
|
| Sus scrofa | 1 | 2018 | 27 | 0.150 |
Why?
|
| Swine | 2 | 2020 | 352 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2017 | 884 | 0.150 |
Why?
|
| Respiratory Mechanics | 1 | 2018 | 57 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2020 | 173 | 0.150 |
Why?
|
| NFATC Transcription Factors | 1 | 2018 | 20 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2018 | 65 | 0.150 |
Why?
|
| Benchmarking | 1 | 2019 | 135 | 0.150 |
Why?
|
| Acetyl Coenzyme A | 1 | 2018 | 22 | 0.150 |
Why?
|
| Diphenylamine | 1 | 2017 | 4 | 0.150 |
Why?
|
| Male | 5 | 2024 | 27751 | 0.150 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 26 | 0.150 |
Why?
|
| Plastics | 1 | 2017 | 19 | 0.140 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 471 | 0.140 |
Why?
|
| Hydrogen | 1 | 2017 | 50 | 0.140 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 161 | 0.140 |
Why?
|
| rho-Associated Kinases | 2 | 2009 | 11 | 0.140 |
Why?
|
| Benzamides | 1 | 2017 | 63 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2017 | 74 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 89 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2009 | 140 | 0.140 |
Why?
|
| Macrophages | 2 | 2024 | 1015 | 0.140 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 207 | 0.140 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 256 | 0.140 |
Why?
|
| Software | 1 | 2020 | 366 | 0.140 |
Why?
|
| Cystatin C | 1 | 2016 | 8 | 0.130 |
Why?
|
| Cathepsin L | 1 | 2016 | 21 | 0.130 |
Why?
|
| Linear Models | 1 | 2017 | 403 | 0.130 |
Why?
|
| Calcium Signaling | 1 | 2018 | 153 | 0.130 |
Why?
|
| Cathepsins | 1 | 2016 | 34 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2017 | 513 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 357 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2017 | 211 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 516 | 0.130 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 59 | 0.130 |
Why?
|
| Leucine | 1 | 2016 | 61 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2018 | 155 | 0.130 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1304 | 0.130 |
Why?
|
| Aorta | 2 | 2008 | 108 | 0.130 |
Why?
|
| Collagen | 2 | 2014 | 115 | 0.120 |
Why?
|
| Protease Inhibitors | 1 | 2016 | 104 | 0.120 |
Why?
|
| Actins | 2 | 2008 | 259 | 0.120 |
Why?
|
| Bacterial Adhesion | 1 | 2015 | 58 | 0.120 |
Why?
|
| Pectins | 1 | 2015 | 57 | 0.120 |
Why?
|
| Transcriptome | 1 | 2017 | 340 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2015 | 183 | 0.110 |
Why?
|
| Chitosan | 1 | 2015 | 82 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 74 | 0.110 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 169 | 0.110 |
Why?
|
| Elasticity | 3 | 2015 | 40 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2020 | 616 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 66 | 0.110 |
Why?
|
| Polylysine | 1 | 2013 | 49 | 0.110 |
Why?
|
| Mutation | 1 | 2021 | 2456 | 0.100 |
Why?
|
| Heparin | 1 | 2013 | 111 | 0.100 |
Why?
|
| Breast | 1 | 2014 | 173 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2011 | 48 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 392 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2011 | 110 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 226 | 0.090 |
Why?
|
| Phenotype | 1 | 2015 | 1137 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 98 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2015 | 695 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 276 | 0.090 |
Why?
|
| 3T3 Cells | 2 | 2007 | 108 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2011 | 196 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 53 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2009 | 46 | 0.080 |
Why?
|
| Acrylic Resins | 2 | 2006 | 17 | 0.080 |
Why?
|
| Vinculin | 1 | 2008 | 3 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 105 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 117 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 584 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2008 | 359 | 0.070 |
Why?
|
| Polystyrenes | 1 | 2007 | 32 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2008 | 197 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 250 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 205 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2006 | 128 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2053 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2007 | 146 | 0.060 |
Why?
|
| Amides | 1 | 2005 | 52 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 217 | 0.060 |
Why?
|
| Actin Cytoskeleton | 1 | 2005 | 75 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2006 | 195 | 0.060 |
Why?
|
| Pyridines | 1 | 2005 | 98 | 0.060 |
Why?
|
| Morphogenesis | 1 | 2025 | 108 | 0.060 |
Why?
|
| Regeneration | 1 | 2025 | 93 | 0.060 |
Why?
|
| Liposomes | 1 | 2024 | 100 | 0.060 |
Why?
|
| Caspase 1 | 1 | 2024 | 107 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2007 | 486 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 205 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 349 | 0.050 |
Why?
|
| Melanoma | 1 | 2007 | 329 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 327 | 0.050 |
Why?
|
| Lipids | 1 | 2024 | 300 | 0.050 |
Why?
|
| Cell Line | 3 | 2015 | 1984 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 404 | 0.050 |
Why?
|
| Ethiopia | 1 | 2021 | 4 | 0.050 |
Why?
|
| Gray Matter | 1 | 2020 | 31 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 3615 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 184 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 57 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 245 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 21 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2024 | 493 | 0.040 |
Why?
|
| Integrin-Binding Sialoprotein | 2 | 2009 | 5 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1552 | 0.040 |
Why?
|
| Sialoglycoproteins | 2 | 2009 | 21 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 95 | 0.040 |
Why?
|
| Osteocalcin | 2 | 2009 | 47 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 545 | 0.040 |
Why?
|
| Alkaline Phosphatase | 2 | 2009 | 46 | 0.040 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 17 | 0.040 |
Why?
|
| Acetylation | 1 | 2018 | 113 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 258 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2018 | 102 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 743 | 0.030 |
Why?
|
| Collagen Type I | 2 | 2007 | 39 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 1491 | 0.030 |
Why?
|
| RNA Interference | 1 | 2020 | 590 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2016 | 24 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1792 | 0.030 |
Why?
|
| Cytokines | 1 | 2020 | 915 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 623 | 0.030 |
Why?
|
| Methacrylates | 1 | 2015 | 37 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 475 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 365 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2016 | 270 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 445 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 399 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 458 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 2905 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2015 | 126 | 0.030 |
Why?
|
| Nanostructures | 1 | 2016 | 174 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 450 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2013 | 88 | 0.030 |
Why?
|
| Apoptosis | 1 | 2018 | 1032 | 0.030 |
Why?
|
| Child | 1 | 2021 | 4186 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5124 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 15 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2011 | 16 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 52 | 0.020 |
Why?
|
| Urea | 1 | 2011 | 35 | 0.020 |
Why?
|
| Albumins | 1 | 2011 | 34 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 48 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 5835 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1128 | 0.020 |
Why?
|
| Compliance | 1 | 2009 | 5 | 0.020 |
Why?
|
| Bone Matrix | 1 | 2009 | 3 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2009 | 3 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2009 | 20 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2009 | 142 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 241 | 0.020 |
Why?
|
| Fibrin | 1 | 2007 | 18 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 1910 | 0.020 |
Why?
|
| Epidermis | 1 | 2007 | 35 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 13415 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 354 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 15687 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 16320 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 651 | 0.010 |
Why?
|